The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago ...

Warning of a "silent pandemic" spreading across the globe, Pfizer is taking the fight against antimicrobial resistance Down ...

Servier has expanded its IDH drug armamentarium with the FDA approval for an IDH1/2 dual inhibitor. | Servier's Voranigo, or ...

Bayer’s transformation under CEO Bill Anderson has picked up momentum. In reporting second-quarter earnings on Tuesday, the ...

Amid Bayer's massive reorganization, the company's pharma group is moving | The company plans to keep building out ...

Following a string of legal wins this year—plus one major setback in May—GSK has washed its hands of yet another lawsuit ...

The reorg comes with cost cuts across the medicine's R&D, manufacturing and commercialization support functions.

IBSA previously turned to professional golfer James Hahn in 2022 to help promote Licart—and tapped another golfer, the LPGA’s ...

Meet the Damouni Group, a new comms and corporate affairs agency launching this month founded and led by Sasha Damouni Ellis.

Incyte is asking viewers to imagine a drug ad that provokes more excitement than eye rolls. Attaching a self-deprecating ...

The FDA hit Eugia, a unit of Indian drugmaker Aurobindo, with a classification of “Official Action Indicated” in the wake of a plant inspection at its Bhiwadi Unit II facility in April and May. The ...

Months of an ongoing supply squeeze for Eli Lilly’s tirzepatide-based meds have lifted, according to the FDA. | The update to ...